TY - JOUR
T1 - Esophageal Hypervigilance and Symptom-Specific Anxiety in Patients with Eosinophilic Esophagitis
AU - Taft, Tiffany H.
AU - Carlson, Dustin A.
AU - Simons, Madison
AU - Zavala, Sonia
AU - Hirano, Ikuo
AU - Gonsalves, Nirmala
AU - Pandolfino, John E.
N1 - Funding Information:
Funding Research reported in this publication was supported by th National Institute of Diabetes Digestive Disease and Kidney (NIDDK) of the National Institutes of Health under award number 1P01DK117824-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funding Information:
Tiffany H. Taft, PsyD (Conceptualization: Lead; Formal analysis: Lead; Methodology: Equal; Writing – original draft: Lead; Writing – review & editing: Lead). Dustin A. Carlson, MD (Data curation: Lead; Formal analysis: Supporting; Methodology: Supporting; Project administration: Equal; Writing – original draft: Supporting; Writing – review & editing: Supporting). Madison Simons, PsyD (Data curation: Supporting; Project administration: Supporting; Writing – original draft: Supporting; Writing – review & editing: Supporting). Sonia Zavala, BS (Data curation: Supporting; Project administration: Supporting; Writing – original draft: Supporting; Writing – review & editing: Supporting). Ikuo Hirano, MD (Data curation: Equal; Formal analysis: Supporting; Writing – original draft: Supporting; Writing – review & editing: Supporting). Nirmala Gonsalves, MD (Data curation: Equal; Formal analysis: Supporting; Writing – original draft: Supporting; Writing – review & editing: Supporting). John E. Pandolfino, MD (Conceptualization: Equal; Data curation: Equal; Formal analysis: Equal; Funding acquisition: Lead; Methodology: Supporting; Resources: Lead; Writing – original draft: Equal; Writing – review & editing: Equal). Funding Research reported in this publication was supported by the National Institute of Diabetes Digestive Disease and Kidney (NIDDK) of the National Institutes of Health under award number 1P01DK117824-01 (PI, John E. Pandolfino). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2021 AGA Institute
PY - 2021/10
Y1 - 2021/10
N2 - Background & Aims: Patient symptom reporting often does not correlate with the pathophysiological markers of esophageal disease, including eosinophilic esophagitis (EoE). Esophageal hypervigilance and symptom-specific anxiety are emerging as important considerations in understanding symptom reporting. As such, we aimed to conduct the first study of these constructs in EoE. Methods: A retrospective review of an EoE patient registry was conducted and included eosinophils per high power field (from esophagogastroduodenoscopy biopsy: proximal, distal), endoscopic reference score, distal distensibility plateau (functional luminal imaging probe), Brief Esophageal Dysphagia Questionnaire, Visual Dysphagia Question of EoE Activity Index, Northwestern Esophageal Quality of Life scale, and the Esophageal Hypervigilance and Anxiety Scale. Correlational and regression analyses evaluated relationships of hypervigilance and anxiety with Brief Esophageal Dysphagia Questionnaire, Visual Dysphagia Question of EoE Activity Index, and Northwestern Esophageal Quality of Life scale when controlling for histology and endoscopic severity. Results: One hundred and three patients had complete data, 69.9% were male, and the mean (SD) age was 40.66 (13.85) years. Forty-one percent had elevated dysphagia and 46% had elevated hypervigilance and anxiety. Esophageal symptom–specific anxiety emerged as the most important predictor of Brief Esophageal Dysphagia Questionnaire severity (44.8% of the variance), Visual Dysphagia Question of EoE Activity Index severity (26%), and poor health-related quality of life (HRQoL) (55.3%). Hypervigilance was also important, but to a lesser extent. Pathophysiological variables did not significantly predict symptoms or HRQoL. Recent food impaction can predict symptom-specific anxiety and proton pump inhibitor use can reduce hypervigilance. Conclusions: Hypervigilance and symptom-specific anxiety are important for our understanding of self-reported patient outcomes in EoE. These processes outweigh endoscopic and histologic markers of EoE disease activity across dysphagia, difficulty eating, and HRQoL. Clinicians should assess hypervigilance and anxiety, especially in patients with refractory symptoms and poor HRQoL.
AB - Background & Aims: Patient symptom reporting often does not correlate with the pathophysiological markers of esophageal disease, including eosinophilic esophagitis (EoE). Esophageal hypervigilance and symptom-specific anxiety are emerging as important considerations in understanding symptom reporting. As such, we aimed to conduct the first study of these constructs in EoE. Methods: A retrospective review of an EoE patient registry was conducted and included eosinophils per high power field (from esophagogastroduodenoscopy biopsy: proximal, distal), endoscopic reference score, distal distensibility plateau (functional luminal imaging probe), Brief Esophageal Dysphagia Questionnaire, Visual Dysphagia Question of EoE Activity Index, Northwestern Esophageal Quality of Life scale, and the Esophageal Hypervigilance and Anxiety Scale. Correlational and regression analyses evaluated relationships of hypervigilance and anxiety with Brief Esophageal Dysphagia Questionnaire, Visual Dysphagia Question of EoE Activity Index, and Northwestern Esophageal Quality of Life scale when controlling for histology and endoscopic severity. Results: One hundred and three patients had complete data, 69.9% were male, and the mean (SD) age was 40.66 (13.85) years. Forty-one percent had elevated dysphagia and 46% had elevated hypervigilance and anxiety. Esophageal symptom–specific anxiety emerged as the most important predictor of Brief Esophageal Dysphagia Questionnaire severity (44.8% of the variance), Visual Dysphagia Question of EoE Activity Index severity (26%), and poor health-related quality of life (HRQoL) (55.3%). Hypervigilance was also important, but to a lesser extent. Pathophysiological variables did not significantly predict symptoms or HRQoL. Recent food impaction can predict symptom-specific anxiety and proton pump inhibitor use can reduce hypervigilance. Conclusions: Hypervigilance and symptom-specific anxiety are important for our understanding of self-reported patient outcomes in EoE. These processes outweigh endoscopic and histologic markers of EoE disease activity across dysphagia, difficulty eating, and HRQoL. Clinicians should assess hypervigilance and anxiety, especially in patients with refractory symptoms and poor HRQoL.
KW - Eosinophilic Esophagitis
KW - Hypervigilance
KW - Quality of Life
KW - Symptom Severity
KW - Symptom-Specific Anxiety
UR - http://www.scopus.com/inward/record.url?scp=85111595276&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111595276&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2021.06.023
DO - 10.1053/j.gastro.2021.06.023
M3 - Article
C2 - 34153298
AN - SCOPUS:85111595276
SN - 0016-5085
VL - 161
SP - 1133
EP - 1144
JO - Gastroenterology
JF - Gastroenterology
IS - 4
ER -